These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 7678571)
1. Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy. Smith HO; Stringer CA; Kavanagh JJ; Gershenson DM; Edwards CL; Wharton JT Gynecol Oncol; 1993 Jan; 48(1):11-5. PubMed ID: 7678571 [TBL] [Abstract][Full Text] [Related]
2. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy. Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza. Zanetta G; Fei F; Mangioni C Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol. Chambers SK; Lamb L; Kohorn EI; Schwartz PE; Chambers JT Gynecol Oncol; 1994 May; 53(2):161-9. PubMed ID: 7514557 [TBL] [Abstract][Full Text] [Related]
5. Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group. Picozzi VJ; Sikic BI; Carlson RW; Koretz M; Ballon SC Cancer Treat Rep; 1985; 69(7-8):903-5. PubMed ID: 2410123 [TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with cisplatin and bleomycin in advanced cervical cancer. Bloch B; Nel CP; Kriel A; Atad J; Goldberg G Cancer Treat Rep; 1984 Jun; 68(6):891-3. PubMed ID: 6203640 [TBL] [Abstract][Full Text] [Related]
7. Epirubicin and cisplatin in recurrent, metastatic or advanced carcinoma of the cervix. Lorvidhaya V Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():252-5. PubMed ID: 7661592 [TBL] [Abstract][Full Text] [Related]
8. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix. Lin JC; Ho ES; Jan JS; Yang CH; Liu FS Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094 [TBL] [Abstract][Full Text] [Related]
9. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type. Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480 [TBL] [Abstract][Full Text] [Related]
10. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer? Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S J BUON; 2009; 14(2):203-9. PubMed ID: 19650167 [TBL] [Abstract][Full Text] [Related]
11. [A combination chemotherapy using mitomycin C, vincristine and cisplatin (MVP) for advanced cervical cancer]. Ikeda K; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Usui N; Nakada H; Adachi K; Yamazaki H; Tada A Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):536-40. PubMed ID: 4004284 [TBL] [Abstract][Full Text] [Related]
12. A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix. Morris M; Gershenson DM; Burke TW; Mitchell MF; Levenback C; Atkinson N; Wharton JT Gynecol Oncol; 1994 May; 53(2):234-8. PubMed ID: 8188085 [TBL] [Abstract][Full Text] [Related]
13. Bleomycin-adriamycin-cisplatin combination chemotherapy in the treatment of primary advanced and recurrent cervical carcinoma. Sorbe B; Frankendal B Obstet Gynecol; 1984 Feb; 63(2):167-70. PubMed ID: 6198610 [TBL] [Abstract][Full Text] [Related]
14. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix. Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129 [TBL] [Abstract][Full Text] [Related]
15. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma]. Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288 [TBL] [Abstract][Full Text] [Related]
16. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer. Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518 [TBL] [Abstract][Full Text] [Related]
17. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix. Singhal RM; Jindel R; Gupta AK Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix. Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350 [TBL] [Abstract][Full Text] [Related]